Compounds > docetaxel anhydrous
Page last updated: 2024-09-04

docetaxel anhydrous and Lassitude

docetaxel anhydrous has been researched along with Lassitude in 70 studies

Research

Studies (70)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's25 (35.71)29.6817
2010's37 (52.86)24.3611
2020's8 (11.43)2.80

Authors

AuthorsStudies
Hirahara, N; Hyakudomi, R; Ishitobi, K; Kaji, S; Matsubara, T; Tajima, Y; Takai, K; Uchida, Y; Yamamoto, T1
Byeon, S; Jeon, HG; Jeon, SS; Kim, H; Lee, HM; Lee, SI; Park, SH; Seo, SI1
Dietz, A; Fietkau, R; Frickhofen, N; Gauler, T; Goerling, U; Große-Thie, C; Grünwald, V; Guntinas-Lichius, O; Haxel, B; Keilholz, U; Klinghammer, K; Knipping, S; Knoedler, M; Lindeman, HW; Martus, P; Maschmeyer, G; Zipfel, M1
Hashimoto, M; Hojo, M; Iikura, M; Ishida, A; Ishii, S; Izumi, S; Naka, G; Sugiyama, H; Ushio, A1
Alibhai, SMH; Breunis, H; Emmenegger, U; Gregg, R; Hansen, AR; Kim, VS; Timilshina, N; Tomlinson, G; Yang, H1
Boere, I; Gennigens, C; Hanssen, R; Jalving, M; Ledermann, J; Mathijssen, RHJ; Ottevanger, P; Rijcken, CJF; van de Wouw, YJ; Vergote, I1
Ayari, J; Balti, M; Ben Abdallah, I; Ben Hassen, M; Ben Nasr, S; Doghri, Y; Fendri, S; Haddaoui, A; Trigui, E; Zribi, A1
Beijnen, JH; de Weger, VA; Huitema, ADR; Janssen, JM; Keessen, M; Lopez-Yurda, MI; Marchetti, S; Rosing, H; Thijssen, B; Vermunt, MAC1
Ahn, JS; Awada, A; Cortés, J; Diéras, V; Gómez-Pardo, P; Hannah, AL; Hoch, U; Im, SA; Mailliez, A; Moreno-Aspitia, A; O'Shaughnessy, J; Perez, EA; Potter, DA; Rugo, HS; Schwartzberg, LS; Tagliaferri, M; Twelves, C; Yardley, DA; Zhao, C1
Bergin, ART; de Souza, P; Hovey, E; Lloyd, A; Marx, G; Parente, P; Rapke, T1
Blaydorn, L; Coats, J; Farley, JH; Khemka, V; Lynch, CA; McGahey, K; Niu, J; Sangal, A; Waypa, J; Weiss, GJ1
Goldberg, KB; Khozin, S; Kim, G; Pazdur, R; Suzman, D; Tang, S; Wahby, S; Weinstock, C; Zhang, L1
Crumbaker, M; Gurney, H1
Arun, B; Babiera, GV; Basen-Engquist, K; Chaoul, A; Cohen, L; Engle, R; Hall, MH; Harrison, CA; Li, Y; Milbury, K; Perkins, GH; Shih, YT; Spelman, A; Valero, V; Wangyal, T; Wei, Q1
Alva, A; Anderson, J; Autio, KA; Dittamore, R; Dreicer, R; Garcia, JA; Graf, RP; Hart, LL; Milowsky, MI; Morris, MJ; Posadas, EM; Ryan, CJ; Scher, HI; Schreiber, NA; Summa, JM; Youssoufian, H1
Argiris, A; Burtness, B; Forastiere, AA; Ghebremichael, M; Gilbert, J; Kolesar, JM; Lee, JW; Sachidanandam, K1
Cataruozolo, PE; Cesari, R; Collier, M; Cortés, J; Curigliano, G; Elias, A; Goldhirsch, A; Huang, X; Kern, KA; Khosravan, R; Pivot, X1
Chi, KN; Fizazi, K; Haqq, CM; Higano, CS; Kheoh, T; Li, J; Marberger, M; Molina, A; Mulders, PF; Saad, F1
Bahl, A; Castellano, D; Chen, I; Chow Maneval, E; Daugaard, G; Gschwend, J; Houede, N; Jones, R; Laestadius, F; Lechuga, MJ; Maurina, T; Michaelson, MD; Ostler, P; Ou, YC; Oudard, S; Paolini, J; Saad, F; Sengeløv, L; Stenzl, A; Ullèn, A; Wang, SL1
Abdi, E; Bonaventura, A; Craft, P; de Souza, P; Hill, A; Hovey, E; Lloyd, A; Marx, G; Michele, A; Parente, P; Rapke, T1
Biondo, A; Cassier, PA; Chen, E; de Bono, JS; Minton, S; Molife, LR; Papadopoulos, KP; Patnaik, A; Siu, LL; Sullivan, DM; Tetteh, E; Tolcher, AW; Vitfell-Rasmussen, J; Yan, L; Zernhelt, AM1
Baciuchka, M; Berdah, JF; Beuzeboc, P; Bousquet, G; Dauba, J; Delva, R; Deplanque, G; El Kouri, C; Esterni, B; Eymard, JC; Ferrero, JM; Fizazi, K; Gravis, G; Habibian, M; Hasbini, A; Joly, F; Krakowski, I; Labourey, JL; Laguerre, B; Latorzeff, I; Linassier, C; Machiels, JP; Marino, P; Mourey, L; Oudard, S; Platini, C; Pouessel, D; Priou, F; Ravaud, A; Rolland, F; Soulie, M; Suc, E; Théodore, C; Zanetta, S1
Gao, X; Jing, T; Sun, Y; Wang, F; Xu, C; Zhang, C1
Arun, B; Cohen, L; Lam, CY; Ratcliff, CG; Valero, V1
Abi Gerges, D; Buyse, M; Fung, H; Gelmon, KA; Gorbunova, V; Hegg, R; Ibrahim, A; Konecny, GE; Krasnozhon, D; Lipatov, O; Mackey, JR; Manikhas, A; Martin, M; McCarthy, N; Ramos-Vazquez, M; Semiglazov, V; Simms, L; Thireau, F; Verma, S; Webster, M1
Anna, M; Baki, M; Beatrice, D; Calogero, S; Davide, F; Detti, B; Di Brina, L; Di Cataldo, V; Eleonora, MP; Franceschini, D; Furfaro, I; Gabriele, S; Icro, M; Ilaria, F; Livi, L; Lorenzo, L; Lucia, DB; Mancuso, A; Meattini, I; Mohammed, B; Pasquetti, EM; Saieva, C; Simontacchi, G; Vanessa, DC1
Berry, W; Chi, KN; Dmuchowski, C; Emmenegger, U; Foley, MA; Haas, NB; Hasabou, N; Hirmand, M; Joshua, AM; Mukherjee, SD; Olsson, CA; Perabo, F; Rathkopf, D; Saad, F; Scholz, M; Shore, ND; Winquist, E1
Beijnen, JH; Boot, H; Cats, A; Deenen, MJ; Legdeur, MC; Meulendijks, D; Schellens, JH1
Hara, F; Hozumi, Y; Imoto, S; Matsubara, N; Mukai, H; Nishimura, R; Ohashi, Y; Park, Y; Sagara, Y; Saito, T; Shimozuma, K; Takano, T; Takashima, T; Toyama, T; Tsurutani, J; Watanabe, T1
Cooray, P; Ferraro, DA; Ganju, V; Gebski, V; Hall, M; Pavlakis, N; Price, TJ; Shannon, JA; Sjoquist, KM; Strickland, A; Tebbutt, NC; Underhill, C; Varma, SC; Veillard, AS; Wong, N; Young, R1
Dermitzaki, EK; Georgoulias, V; Hatzidaki, D; Karavassilis, V; Katsaounis, P; Kentepozidis, N; Koinis, F; Kotsakis, A; Matikas, A; Mavroudis, D; Samantas, E; Varthalitis, II1
Altundag, K; Barnadas, A; Botha, M; Chan, A; Cinieri, S; Coskun, U; Dodyk, P; Lazzarelli, S; Rauch, D; Tubiana-Mathieu, N; Vandebroek, A; Villanova, G1
Eggemann, H; Elling, D; Harbeck, N; Janni, W; Kaufmann, M; Kiechle, M; Kümmel, S; Loibl, S; Nekljudova, V; Sommer, H; von Minckwitz, G1
Beer, TM; Blanke, CD; Lopez, C; Mori, M; Stone, M; Todd, K1
Johnson, MM; Jones, D; Logothetis, CJ; Mathew, P; Tu, SM; Wong, FC1
Abdul-Karim, F; Baar, J; Chen, H; Dowlati, A; Dumadag, L; Fu, P; Hartman, P; Hohler, E; Jesberger, J; Leeming, R; Lyons, J; McCrae, K; Overmoyer, B; Remick, SC; Shenk, R; Silverman, P; Wasman, J; Ziats, N1
Clark, JI; Gajewski, TF; Locke, F1
Dueck, A; Jatoi, A; Loprinzi, CL; Luyun, RF; Mattar, BI; Nguyen, PL; Nikcevich, DA; Ritter, HL1
Foster, J; Lee, J; Urba, S; Worden, F; Zhang, J1
Bernal, P; Byrd, J; Malik, I1
Federico, K; Lloyd, GK; Mainwaring, P; Millward, M; Mita, A; Mita, M; Nawrocki, S; Reddinger, N; Spear, MA1
Boni, L; Caffo, O; de Marinis, F; Dondi, D; Ferraù, F; Galligioni, E; Gamucci, T; Gebbia, V; Grossi, F; Moscetti, L; Nardi, M; Riccardi, F1
Daga, H; Hida, T; Horio, Y; Ishikawa, S; Kobayashi, K; Shimizu, J; Takeda, K; Tokunaga, S1
Ancoli-Israel, S; Dimsdale, JE; Fiorentino, L; Liu, L; Mills, PJ; Natarajan, L; Parker, BA; Rissling, M; Sadler, GR1
Berger, AM; Farr, L; Fischer, P; Geary, CR; Hertzog, M1
Bozionelou, V; Georgoulias, V; Kalykaki, A; Karachaliou, N; Kontopodis, E; Mavroudis, D; Papadimitraki, E; Syrigos, K; Tryfonidis, K; Ziras, N1
Assadourian, S; Falandry, C; Favier, L; Freyer, G; Fumoleau, P; Isambert, N; Soussan-Lazard, K; Trillet-Lenoir, V; You, B; Zanetta, S; Ziti-Ljajic, S1
Allred, JB; Apsey, H; Mattar, B; Nikcevich, D; Northfelt, DW; Perez, EA; Pockaj, BA; Roy, V1
Cleeland, C; de Bono, JS; Fizazi, K; Gagnon, DD; Hao, Y; Haqq, CM; Kheoh, T; Mainwaring, P; Molina, A; North, S; Rothman, M; Scher, HI; Sternberg, CN1
Colowick, AB; Fleishman, A; Glaspy, JA; Jadeja, JS; Justice, G; Rossi, G1
Kuzuya, K; Mizutani, S; Nakanishi, T; Nawa, A; Niwa, Y1
Hirano, T; Kubo, H; Masaki, K; Ogura, H; Taoka, H; Terauchi, F; Yamamoto, Y1
Dancey, J; Gralla, RJ; Kim, YS; Shepherd, FA1
Hainsworth, JD1
Cao, CW; Gao, Y; Guo, J; Shi, ZQ; Zhu, CL1
Almuete, VI; Armstrong, DK; Baker, SD; Carducci, MA; Dinh, K; Donehower, RC; Lassiter, L; Messersmith, WA; Sullivan, RA; Wright, JJ1
Caligiuri, MA; Criswell, T; Guttridge, D; Kuhn, J; Monk, JP; Otterson, GA; Phillips, G; Rhoades, C; Schaaf, LJ; Shah, M; Villalona-Calero, MA; Waite, R1
James, J; Miller, KD; Murry, DJ; Sidor, C; Sledge, GW; Storniolo, AM; Treston, AM1
Azuma, K; Hashine, K; Miura, N; Numata, K; Sumiyoshi, Y1
Auliac, JB; Barlesi, F; Bombaron, P; Chouaid, C; Crequit, J; Falchero, L; Fournel, P; Geriniere, L; LeCaer, H; Robinet, G1
Jiang, WQ; Shi, YX; Wang, XX; Yuan, ZY; Zhang, DS; Zhou, ZM1
Chahine, GY; Farhat, FS; Ghosn, MG; Kattan, JG; Moukadem, WT; Nasr, FL; Yazbeck, NJ; Younes, FC1
Addison, R; Basche, M; Chow, LQ; Creese, BR; Davis, K; Eckhardt, SG; Gore, L; Grolnic, S; Gustafson, DL; Holden, SN; Morrow, MC; O'Bryant, CL; Roberts, KL1
Baggstrom, MQ; Fracasso, PM; Govindan, R; Read, W; Suresh, R; Wildi, JD1
Akaza, H; Harabayashi, T; Hoshi, S; Koga, H; Naito, S; Sumiyoshi, Y; Tsukamoto, T1
Beijnen, JH; Bult, A; Huizing, MT; Lustig, V; Rodenhuis, S; Rosing, H; Schellens, JH; ten Bokkel Huinink, WW; van Warmerdam, LJ1
Bol, CJ; Palmer, PA; Sparreboom, A; van Beurden, V; van der Burg, ME; van der Gaast, A; van Zuylen, L; Verweij, J; Woestenborghs, R1
Atkinson, R; Coleman, R; Crawford, M; Cruickshank, M; Eggleton, P; Fleming, D; Graham, J; Kaye, SB; Parkin, D; Paul, J; Reed, NS; Vasey, PA1
Baldelli, AM; Barni, S; Casaretti, R; Cascinu, S; Catalano, G; Catalano, V; Comella, G; Frontini, L; Graziano, F; Labianca, R1
Depisch, D; Haider, K; Kornek, GV; Kovats, E; Kwasny, W; Lang, F; Payrits, T; Raderer, M; Scheithauer, W; Schüll, B1

Reviews

4 review(s) available for docetaxel anhydrous and Lassitude

ArticleYear
Dose considerations for anti-cancer drugs in metastatic prostate cancer.
    The Prostate, 2017, Volume: 77, Issue:11

    Topics: Antineoplastic Agents; Antineoplastic Combined Chemotherapy Protocols; Cognition Disorders; Docetaxel; Dose-Response Relationship, Drug; Fatigue; Humans; Male; Precision Medicine; Prostatic Neoplasms, Castration-Resistant; Taxoids

2017
Chemotherapy plus estramustine for management of castration-resistant prostate cancer: meta-analysis of randomized controlled trials.
    Actas urologicas espanolas, 2014, Volume: 38, Issue:3

    Topics: Adenocarcinoma; Antineoplastic Agents, Hormonal; Antineoplastic Combined Chemotherapy Protocols; Cardiovascular Diseases; Combined Modality Therapy; Docetaxel; Epirubicin; Epothilones; Estramustine; Fatigue; Gastrointestinal Diseases; Hematologic Diseases; Humans; Male; Orchiectomy; Paclitaxel; Peripheral Nervous System Diseases; Prostate-Specific Antigen; Prostatic Neoplasms; Randomized Controlled Trials as Topic; Salvage Therapy; Survival Analysis; Taxoids; Treatment Outcome; Vinblastine

2014
Clinical feasibility of (neo)adjuvant taxane-based chemotherapy in older patients: analysis of >4,500 patients from four German randomized breast cancer trials.
    Breast cancer research : BCR, 2008, Volume: 10, Issue:5

    Topics: Age Factors; Aged; Aged, 80 and over; Antineoplastic Combined Chemotherapy Protocols; Capecitabine; Chemotherapy, Adjuvant; Cyclophosphamide; Deoxycytidine; Docetaxel; Dose-Response Relationship, Drug; Epirubicin; Fatigue; Feasibility Studies; Female; Fluorouracil; Gastrointestinal Diseases; Germany; Hematologic Diseases; Humans; Middle Aged; Neoadjuvant Therapy; Paclitaxel; Prospective Studies; Randomized Controlled Trials as Topic; Taxoids; Vinblastine; Vinorelbine

2008
Practical aspects of weekly docetaxel administration schedules.
    The oncologist, 2004, Volume: 9, Issue:5

    Topics: Age Factors; Antineoplastic Agents, Phytogenic; Docetaxel; Drug Administration Schedule; Fatigue; Humans; Infusions, Intravenous; Neoplasms; Neutropenia; Palliative Care; Taxoids

2004

Trials

58 trial(s) available for docetaxel anhydrous and Lassitude

ArticleYear
Phase II feasibility study of adjuvant chemotherapy with docetaxel/cisplatin/S-1 followed by S-1 for stage III gastric cancer.
    BMC cancer, 2021, Oct-01, Volume: 21, Issue:1

    Topics: Adenocarcinoma; Aged; Anemia; Anorexia; Antineoplastic Combined Chemotherapy Protocols; Chemotherapy-Induced Febrile Neutropenia; Chemotherapy, Adjuvant; Cisplatin; Docetaxel; Drug Administration Schedule; Drug Combinations; Fatigue; Feasibility Studies; Female; Humans; Leukopenia; Male; Middle Aged; Neutropenia; Oxonic Acid; Patient Compliance; Stomach Neoplasms; Tegafur

2021
A prospective phase-II trial of biweekly docetaxel plus androgen deprivation therapy in patients with previously-untreated metastatic castration-naïve prostate cancer.
    BMC cancer, 2021, Nov-29, Volume: 21, Issue:1

    Topics: Aged; Aged, 80 and over; Androgen Antagonists; Anemia; Antineoplastic Agents; Diarrhea; Disease-Free Survival; Docetaxel; Drug Administration Schedule; Fatigue; Follow-Up Studies; Humans; Male; Middle Aged; Nail Diseases; Neutropenia; Pneumonia; Prospective Studies; Prostate-Specific Antigen; Prostatic Neoplasms; Prostatic Neoplasms, Castration-Resistant; Stomatitis

2021
Quality of Life of Patients with Head and Neck Cancer Receiving Cetuximab, Fluorouracil, Cisplatin Comparing to Cetuximab, Fluorouracil, Cisplatin, and Docetaxel within the CEFCID Trial.
    Oncology research and treatment, 2022, Volume: 45, Issue:6

    Topics: Antineoplastic Combined Chemotherapy Protocols; Cetuximab; Cisplatin; Docetaxel; Fatigue; Fluorouracil; Head and Neck Neoplasms; Humans; Neoplasm Recurrence, Local; Quality of Life; Squamous Cell Carcinoma of Head and Neck

2022
CINOVA: a phase II study of CPC634 (nanoparticulate docetaxel) in patients with platinum resistant recurrent ovarian cancer.
    International journal of gynecological cancer : official journal of the International Gynecological Cancer Society, 2023, 08-07, Volume: 33, Issue:8

    Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Ovarian Epithelial; Docetaxel; Drug Resistance, Neoplasm; Fatigue; Female; Humans; Middle Aged; Neoplasm Recurrence, Local; Ovarian Neoplasms; Young Adult

2023
Effect of Food on the Pharmacokinetics of the Oral Docetaxel Tablet Formulation ModraDoc006 Combined with Ritonavir (ModraDoc006/r) in Patients with Advanced Solid Tumours.
    Drugs in R&D, 2021, Volume: 21, Issue:1

    Topics: Administration, Oral; Aged; Antineoplastic Agents; Area Under Curve; Cross-Over Studies; Cytochrome P-450 CYP3A Inhibitors; Diarrhea; Diet, High-Fat; Docetaxel; Drug Combinations; Fasting; Fatigue; Female; Food-Drug Interactions; Humans; Hypokalemia; Male; Middle Aged; Neoplasms; Ritonavir; Tablets; Therapeutic Equivalency

2021
Health-related quality of life in patients with locally recurrent or metastatic breast cancer treated with etirinotecan pegol versus treatment of physician's choice: Results from the randomised phase III BEACON trial.
    European journal of cancer (Oxford, England : 1990), 2017, Volume: 76

    Topics: Activities of Daily Living; Adult; Aged; Aged, 80 and over; Albumins; Anorexia; Antineoplastic Agents; Body Image; Bone Neoplasms; Brain Neoplasms; Breast Neoplasms; Cancer Pain; Deoxycytidine; Docetaxel; Dyspnea; Epothilones; Fatigue; Female; Furans; Gemcitabine; Health Status; Heterocyclic Compounds, 4 or More Rings; Humans; Ketones; Liver Neoplasms; Lung Neoplasms; Middle Aged; Nausea; Paclitaxel; Polyethylene Glycols; Quality of Life; Reproductive Health; Sleep Initiation and Maintenance Disorders; Taxoids; Vinblastine; Vinorelbine; Vomiting

2017
Docetaxel-related fatigue in men with metastatic prostate cancer: a descriptive analysis.
    Supportive care in cancer : official journal of the Multinational Association of Supportive Care in Cancer, 2017, Volume: 25, Issue:9

    Topics: Aged; Aged, 80 and over; Benzhydryl Compounds; Docetaxel; Double-Blind Method; Fatigue; Humans; Male; Middle Aged; Modafinil; Neoplasm Metastasis; Prostatic Neoplasms; Surveys and Questionnaires; Taxoids

2017
A phase Ib study of pembrolizumab plus chemotherapy in patients with advanced cancer (PembroPlus).
    British journal of cancer, 2017, Jun-27, Volume: 117, Issue:1

    Topics: Adenocarcinoma; Adult; Aged; Albumins; Antibodies, Monoclonal, Humanized; Antineoplastic Combined Chemotherapy Protocols; Breast Neoplasms; Camptothecin; Carcinoma, Non-Small-Cell Lung; Deoxycytidine; Diarrhea; Docetaxel; Doxorubicin; Drug Eruptions; Fatigue; Female; Gemcitabine; Humans; Irinotecan; Lung Neoplasms; Male; Middle Aged; Nausea; Neoplasms; Ovarian Neoplasms; Paclitaxel; Pancreatic Neoplasms; Polyethylene Glycols; Sarcoma; Small Cell Lung Carcinoma; Taxoids; Treatment Outcome; Vinblastine; Vinorelbine; Vomiting

2017
Randomized trial of Tibetan yoga in patients with breast cancer undergoing chemotherapy.
    Cancer, 2018, Jan-01, Volume: 124, Issue:1

    Topics: Actigraphy; Adult; Antineoplastic Agents; Antineoplastic Combined Chemotherapy Protocols; Breast Neoplasms; Chemotherapy, Adjuvant; Cyclophosphamide; Docetaxel; Doxorubicin; Epirubicin; Fatigue; Female; Fluorouracil; Humans; Male; Middle Aged; Muscle Stretching Exercises; Neoadjuvant Therapy; Neoplasm Staging; Sleep; Sleep Wake Disorders; Taxoids; Treatment Outcome; Yoga

2018
Safety and Efficacy of BIND-014, a Docetaxel Nanoparticle Targeting Prostate-Specific Membrane Antigen for Patients With Metastatic Castration-Resistant Prostate Cancer: A Phase 2 Clinical Trial.
    JAMA oncology, 2018, 10-01, Volume: 4, Issue:10

    Topics: Aged; Aged, 80 and over; Antineoplastic Agents; Diarrhea; Disease-Free Survival; Docetaxel; Fatigue; Humans; Male; Middle Aged; Nanoparticles; Nausea; Neoplasm Metastasis; Prostate-Specific Antigen; Prostatic Neoplasms, Castration-Resistant; Treatment Outcome

2018
Phase III randomized, placebo-controlled trial of docetaxel with or without gefitinib in recurrent or metastatic head and neck cancer: an eastern cooperative oncology group trial.
    Journal of clinical oncology : official journal of the American Society of Clinical Oncology, 2013, Apr-10, Volume: 31, Issue:11

    Topics: Adult; Age Factors; Aged; Aged, 80 and over; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Squamous Cell; Diarrhea; Docetaxel; Drug Administration Schedule; ErbB Receptors; Fatigue; Female; Gefitinib; Genotype; Head and Neck Neoplasms; Humans; Kaplan-Meier Estimate; Leukopenia; Male; Middle Aged; Neoplasm Metastasis; Neoplasm Recurrence, Local; Proto-Oncogene Proteins; Proto-Oncogene Proteins c-met; Proto-Oncogene Proteins p21(ras); Quinazolines; ras Proteins; Taxoids; Treatment Outcome

2013
Randomized phase II study of sunitinib versus standard of care for patients with previously treated advanced triple-negative breast cancer.
    Breast (Edinburgh, Scotland), 2013, Volume: 22, Issue:5

    Topics: Adult; Aged; Aged, 80 and over; Anthracyclines; Antineoplastic Agents; Capecitabine; Chemotherapy, Adjuvant; Deoxycytidine; Disease-Free Survival; Docetaxel; Fatigue; Female; Fluorouracil; Gemcitabine; Hand-Foot Syndrome; Humans; Indoles; Middle Aged; Neoplasm Metastasis; Neoplasm Recurrence, Local; Neutropenia; Paclitaxel; Pyrroles; Sunitinib; Survival Rate; Taxoids; Thrombocytopenia; Triple Negative Breast Neoplasms

2013
Efficacy and safety of abiraterone acetate in an elderly patient subgroup (aged 75 and older) with metastatic castration-resistant prostate cancer after docetaxel-based chemotherapy.
    European urology, 2014, Volume: 65, Issue:5

    Topics: Abiraterone Acetate; Adult; Age Factors; Aged; Aged, 80 and over; Androstadienes; Antineoplastic Combined Chemotherapy Protocols; Disease-Free Survival; Docetaxel; Double-Blind Method; Fatigue; Humans; Hypertension; Hypokalemia; Male; Middle Aged; Prednisone; Prostate-Specific Antigen; Prostatic Neoplasms, Castration-Resistant; Steroid 17-alpha-Hydroxylase; Survival Rate; Taxoids

2014
Randomized, placebo-controlled, phase III trial of sunitinib plus prednisone versus prednisone alone in progressive, metastatic, castration-resistant prostate cancer.
    Journal of clinical oncology : official journal of the American Society of Clinical Oncology, 2014, Jan-10, Volume: 32, Issue:2

    Topics: Adult; Aged; Aged, 80 and over; Anemia; Antineoplastic Combined Chemotherapy Protocols; Asthenia; Disease Progression; Disease-Free Survival; Docetaxel; Double-Blind Method; Drug Administration Schedule; Drug Resistance, Neoplasm; Fatigue; Humans; Indoles; Kaplan-Meier Estimate; Lymphopenia; Male; Middle Aged; Neoplasm Metastasis; Orchiectomy; Prednisone; Prostatic Neoplasms; Pyrroles; Sunitinib; Taxoids; Treatment Outcome

2014
Phase III, randomized, double-blind, placebo-controlled study of modafinil for fatigue in patients treated with docetaxel-based chemotherapy.
    Supportive care in cancer : official journal of the Multinational Association of Supportive Care in Cancer, 2014, Volume: 22, Issue:5

    Topics: Aged; Antineoplastic Combined Chemotherapy Protocols; Benzhydryl Compounds; Breast Neoplasms; Docetaxel; Double-Blind Method; Fatigue; Female; Humans; Male; Middle Aged; Modafinil; Nausea; Neoplasm Metastasis; Prostatic Neoplasms; Taxoids; Vomiting; Wakefulness-Promoting Agents

2014
Phase 1 trial of the oral AKT inhibitor MK-2206 plus carboplatin/paclitaxel, docetaxel, or erlotinib in patients with advanced solid tumors.
    Journal of hematology & oncology, 2014, Jan-03, Volume: 7

    Topics: Administration, Oral; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Area Under Curve; Carboplatin; Docetaxel; Dose-Response Relationship, Drug; Erlotinib Hydrochloride; Exanthema; Fatigue; Febrile Neutropenia; Female; Heterocyclic Compounds, 3-Ring; Humans; Male; Middle Aged; Nausea; Neoplasms; Paclitaxel; Proto-Oncogene Proteins c-akt; Quinazolines; Stomatitis; Taxoids; Tinnitus; Treatment Outcome; Young Adult

2014
Patients' self-assessment versus investigators' evaluation in a phase III trial in non-castrate metastatic prostate cancer (GETUG-AFU 15).
    European journal of cancer (Oxford, England : 1990), 2014, Volume: 50, Issue:5

    Topics: Adult; Aged; Aged, 80 and over; Androgen Antagonists; Antineoplastic Combined Chemotherapy Protocols; Arthralgia; Docetaxel; Fatigue; Hot Flashes; Humans; Male; Middle Aged; Neoplasm Metastasis; Outcome Assessment, Health Care; Physician-Patient Relations; Prostatic Neoplasms; Self-Assessment; Sexual Dysfunction, Physiological; Surveys and Questionnaires; Taxoids; Weight Gain; Weight Loss

2014
Primary results of ROSE/TRIO-12, a randomized placebo-controlled phase III trial evaluating the addition of ramucirumab to first-line docetaxel chemotherapy in metastatic breast cancer.
    Journal of clinical oncology : official journal of the American Society of Clinical Oncology, 2015, Jan-10, Volume: 33, Issue:2

    Topics: Adult; Aged; Aged, 80 and over; Antibodies, Monoclonal; Antibodies, Monoclonal, Humanized; Antineoplastic Combined Chemotherapy Protocols; Breast Neoplasms; Disease-Free Survival; Docetaxel; Double-Blind Method; Drug Administration Schedule; Fatigue; Febrile Neutropenia; Female; Hand-Foot Syndrome; Humans; Hypertension; Immunoglobulin G; Kaplan-Meier Estimate; Middle Aged; Neoplasm Recurrence, Local; Ramucirumab; Stomatitis; Taxoids; Treatment Outcome

2015
Safety of enzalutamide in patients with metastatic castration-resistant prostate cancer previously treated with docetaxel: expanded access in North America.
    The Prostate, 2015, Volume: 75, Issue:8

    Topics: Adult; Aged; Aged, 80 and over; Antineoplastic Agents; Benzamides; Docetaxel; Drug Resistance, Neoplasm; Fatigue; Female; Humans; Male; Middle Aged; Nausea; Nitriles; North America; Phenylthiohydantoin; Prostatic Neoplasms, Castration-Resistant; Taxoids; Treatment Outcome

2015
Phase 1a/1b and pharmacogenetic study of docetaxel, oxaliplatin and capecitabine in patients with advanced cancer of the stomach or the gastroesophageal junction.
    Cancer chemotherapy and pharmacology, 2015, Volume: 76, Issue:6

    Topics: Adult; Aged; Alopecia; Antineoplastic Combined Chemotherapy Protocols; Area Under Curve; Capecitabine; Disease-Free Survival; Docetaxel; Esophageal Neoplasms; Esophagogastric Junction; Fatigue; Female; Genetic Predisposition to Disease; Humans; Male; Metabolic Clearance Rate; Middle Aged; Nausea; Organoplatinum Compounds; Oxaliplatin; Pharmacogenetics; Polymorphism, Single Nucleotide; Stomach Neoplasms; Taxoids; Treatment Outcome

2015
Taxanes versus S-1 as the first-line chemotherapy for metastatic breast cancer (SELECT BC): an open-label, non-inferiority, randomised phase 3 trial.
    The Lancet. Oncology, 2016, Volume: 17, Issue:1

    Topics: Aged; Antimetabolites, Antineoplastic; Antineoplastic Agents, Phytogenic; Breast Neoplasms; Disease Progression; Disease-Free Survival; Docetaxel; Drug Combinations; Edema; Fatigue; Female; Follow-Up Studies; Health Status; Humans; Liver Neoplasms; Middle Aged; Neutropenia; Oxonic Acid; Paclitaxel; Receptor, ErbB-2; Receptors, Estrogen; Receptors, Progesterone; Survival Rate; Taxoids; Tegafur

2016
Panitumumab added to docetaxel, cisplatin and fluoropyrimidine in oesophagogastric cancer: ATTAX3 phase II trial.
    British journal of cancer, 2016, Mar-01, Volume: 114, Issue:5

    Topics: Adenocarcinoma; Adult; Aged; Anorexia; Antibodies, Monoclonal; Antineoplastic Combined Chemotherapy Protocols; Capecitabine; Carcinoma, Squamous Cell; Cisplatin; Diarrhea; Disease-Free Survival; Docetaxel; Esophageal Neoplasms; Esophagogastric Junction; Fatigue; Female; Fluorouracil; Humans; Infections; Liver Neoplasms; Lung Neoplasms; Lymphatic Metastasis; Male; Middle Aged; Nausea; Panitumumab; Peritoneal Neoplasms; Stomach Neoplasms; Taxoids; Treatment Outcome; Vomiting

2016
A multicentre phase II trial of cabazitaxel in patients with advanced non-small-cell lung cancer progressing after docetaxel-based chemotherapy.
    British journal of cancer, 2016, 09-27, Volume: 115, Issue:7

    Topics: Adenocarcinoma; Adult; Aged; Aged, 80 and over; Antineoplastic Agents, Phytogenic; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Large Cell; Carcinoma, Non-Small-Cell Lung; Carcinoma, Squamous Cell; Disease-Free Survival; Docetaxel; Drug Resistance, Neoplasm; Drug Substitution; Dyspnea; Fatigue; Female; Gastrointestinal Diseases; Greece; Hematologic Diseases; Humans; Kaplan-Meier Estimate; Lung Neoplasms; Male; Middle Aged; Taxoids; Treatment Outcome

2016
Final Results of the Randomized Phase II NorCap-CA223 Trial Comparing First-Line All-Oral Versus Taxane-Based Chemotherapy for HER2-Negative Metastatic Breast Cancer.
    Clinical breast cancer, 2017, Volume: 17, Issue:2

    Topics: Administration, Intravenous; Administration, Oral; Adult; Aged; Alopecia; Antimetabolites, Antineoplastic; Antineoplastic Agents, Phytogenic; Antineoplastic Combined Chemotherapy Protocols; Breast Neoplasms; Capecitabine; Deoxycytidine; Disease-Free Survival; Docetaxel; Fatigue; Female; Gemcitabine; Humans; Middle Aged; Neoadjuvant Therapy; Neutropenia; Paclitaxel; Quality of Life; Receptor, ErbB-2; Taxoids; Treatment Outcome; Vinblastine; Vinorelbine

2017
Phase II study of calcitriol-enhanced docetaxel in patients with previously untreated metastatic or locally advanced pancreatic cancer.
    Investigational new drugs, 2009, Volume: 27, Issue:4

    Topics: Adult; Aged; Aged, 80 and over; Antineoplastic Agents; Calcitriol; Calcium Channel Agonists; Calcium, Dietary; Disease Progression; Docetaxel; Drug Therapy, Combination; Fatigue; Female; Humans; Hyperglycemia; Male; Middle Aged; Pancreatic Neoplasms; Survival Rate; Taxoids; Treatment Outcome

2009
Phase I study of concurrent weekly docetaxel and repeated samarium-153 lexidronam in patients with castration-resistant metastatic prostate cancer.
    Journal of clinical oncology : official journal of the American Society of Clinical Oncology, 2009, Jul-10, Volume: 27, Issue:20

    Topics: Aged; Aged, 80 and over; Analgesics, Non-Narcotic; Antineoplastic Agents; Cohort Studies; Combined Modality Therapy; Constipation; Docetaxel; Dose-Response Relationship, Drug; Drug Administration Schedule; Fatigue; Feasibility Studies; Humans; Leukocyte Count; Male; Middle Aged; Neoplasm Metastasis; Neutrophils; Orchiectomy; Organometallic Compounds; Organophosphorus Compounds; Pain; Platelet Count; Prostate-Specific Antigen; Prostatic Neoplasms; Radioisotopes; Taxoids

2009
A vasculature-targeting regimen of preoperative docetaxel with or without bevacizumab for locally advanced breast cancer: impact on angiogenic biomarkers.
    Clinical cancer research : an official journal of the American Association for Cancer Research, 2009, May-15, Volume: 15, Issue:10

    Topics: Abdominal Pain; Adult; Aged; Anemia; Antibodies, Monoclonal; Antibodies, Monoclonal, Humanized; Antineoplastic Agents; Antineoplastic Combined Chemotherapy Protocols; Bevacizumab; Biomarkers, Tumor; Breast Neoplasms; Docetaxel; E-Selectin; Fatigue; Female; Humans; Kaplan-Meier Estimate; Leukopenia; Logistic Models; Magnetic Resonance Imaging; Microvessels; Middle Aged; Multivariate Analysis; Preoperative Care; Stomatitis; Taxoids; Vascular Cell Adhesion Molecule-1; Vascular Endothelial Growth Factor A

2009
A phase II study of oxaliplatin, docetaxel, and GM-CSF in patients with previously treated advanced melanoma.
    Cancer chemotherapy and pharmacology, 2010, Volume: 65, Issue:3

    Topics: Adult; Aged; Aged, 80 and over; Anemia; Anorexia; Antineoplastic Combined Chemotherapy Protocols; Diarrhea; Docetaxel; Dose-Response Relationship, Drug; Drug Administration Schedule; Fatigue; Female; Granulocyte-Macrophage Colony-Stimulating Factor; Humans; Male; Melanoma; Middle Aged; Nausea; Organoplatinum Compounds; Oxaliplatin; Taxoids; Treatment Outcome; Young Adult

2010
A placebo-controlled, double-blind trial of infliximab for cancer-associated weight loss in elderly and/or poor performance non-small cell lung cancer patients (N01C9).
    Lung cancer (Amsterdam, Netherlands), 2010, Volume: 68, Issue:2

    Topics: Aged; Aged, 80 and over; Antibodies, Monoclonal; Carcinoma, Non-Small-Cell Lung; Docetaxel; Double-Blind Method; Fatigue; Female; Genetic Association Studies; Genotype; Humans; Infliximab; Lung Neoplasms; Male; Polymorphism, Genetic; Quality of Life; Taxoids; Tumor Necrosis Factor-alpha; Weight Loss

2010
A phase II trial evaluating weekly docetaxel and capecitabine in patients with metastatic or advanced, locally recurrent head and neck cancers.
    Cancer investigation, 2010, Volume: 28, Issue:9

    Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Capecitabine; Case-Control Studies; Deoxycytidine; Disease-Free Survival; Docetaxel; Drug Administration Schedule; Fatigue; Female; Fluorouracil; Head and Neck Neoplasms; Humans; Lymphopenia; Male; Middle Aged; Neoplasm Metastasis; Neoplasm Recurrence, Local; Taxoids; Treatment Outcome

2010
A phase I study of docetaxel, oxaliplatin, & capecitabine (DOC) as first-line therapy of patients with locally advanced or metastatic adenocarcinoma of stomach and GE junction.
    Cancer investigation, 2010, Volume: 28, Issue:8

    Topics: Adenocarcinoma; Adult; Aged; Antimetabolites, Antineoplastic; Antineoplastic Combined Chemotherapy Protocols; Capecitabine; Deoxycytidine; Diarrhea; Docetaxel; Dose-Response Relationship, Drug; Drug Administration Schedule; Esophageal Neoplasms; Fatigue; Fluorouracil; Humans; Male; Middle Aged; Nausea; Neoplasm Staging; Organoplatinum Compounds; Oxaliplatin; Stomach Neoplasms; Taxoids; Vomiting

2010
Phase 1 study of the novel vascular disrupting agent plinabulin (NPI-2358) and docetaxel.
    Investigational new drugs, 2012, Volume: 30, Issue:3

    Topics: Aged; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Non-Small-Cell Lung; Diarrhea; Diketopiperazines; Docetaxel; Fatigue; Female; Humans; Lung Neoplasms; Male; Middle Aged; Nausea; Neutropenia; Pain; Taxoids; Vomiting

2012
A randomised phase II trial of two sequential schedules of docetaxel and cisplatin followed by gemcitabine in patients with advanced non-small-cell lung cancer.
    Cancer chemotherapy and pharmacology, 2012, Volume: 69, Issue:2

    Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Non-Small-Cell Lung; Cisplatin; Deoxycytidine; Docetaxel; Drug Administration Schedule; Fatigue; Female; Gemcitabine; Humans; Kaplan-Meier Estimate; Leukopenia; Lung Neoplasms; Male; Middle Aged; Neoplasm Staging; Neutropenia; Taxoids; Treatment Outcome

2012
The safety and tolerability of intravenous ASA404 when administered in combination with docetaxel (60 or 75 mg/m²) in Japanese patients with advanced or recurrent solid tumors.
    Japanese journal of clinical oncology, 2011, Volume: 41, Issue:9

    Topics: Aged; Alopecia; Angiogenesis Inhibitors; Antineoplastic Combined Chemotherapy Protocols; Appetite; Asian People; Constipation; Docetaxel; Drug Administration Schedule; Fatigue; Female; Fever; Granulocyte Colony-Stimulating Factor; Humans; Infusions, Intravenous; Male; Middle Aged; Neoplasms; Neutropenia; Severity of Illness Index; Taxoids; Treatment Outcome; Xanthones

2011
Circadian rhythms, symptoms, physical functioning, and body mass index in breast cancer survivors.
    Journal of cancer survivorship : research and practice, 2012, Volume: 6, Issue:3

    Topics: Activities of Daily Living; Adult; Affective Symptoms; Aged; Aged, 80 and over; Antineoplastic Combined Chemotherapy Protocols; Anxiety; Body Mass Index; Breast Neoplasms; Circadian Rhythm; Cyclophosphamide; Depression; Docetaxel; Doxorubicin; Fatigue; Female; Humans; Middle Aged; Paclitaxel; Quality of Life; Sleep; Survivors; Taxoids

2012
A multicenter phase II trial of docetaxel and capecitabine as salvage treatment in anthracycline- and taxane-pretreated patients with metastatic breast cancer.
    Cancer chemotherapy and pharmacology, 2012, Volume: 70, Issue:1

    Topics: Adult; Aged; Anthracyclines; Antineoplastic Combined Chemotherapy Protocols; Breast Neoplasms; Bridged-Ring Compounds; Capecitabine; Deoxycytidine; Disease Progression; Docetaxel; Drug Administration Schedule; Fatigue; Female; Fever; Fluorouracil; Hand-Foot Syndrome; Humans; Middle Aged; Neoplasm Metastasis; Nervous System Diseases; Neutropenia; Remission Induction; Salvage Therapy; Taxoids; Treatment Outcome

2012
Phase I dose-escalation study of aflibercept in combination with docetaxel and cisplatin in patients with advanced solid tumours.
    British journal of cancer, 2012, Aug-07, Volume: 107, Issue:4

    Topics: Aged; Antineoplastic Combined Chemotherapy Protocols; Cisplatin; Docetaxel; Drug Administration Schedule; Fatigue; Female; Humans; Male; Middle Aged; Neoplasms; Neutropenia; Receptors, Vascular Endothelial Growth Factor; Recombinant Fusion Proteins; Taxoids

2012
A Phase II trial of docetaxel and carboplatin administered every 2 weeks as preoperative therapy for stage II or III breast cancer: NCCTG study N0338.
    American journal of clinical oncology, 2013, Volume: 36, Issue:6

    Topics: Adult; Aged; Anemia; Antineoplastic Combined Chemotherapy Protocols; Breast Neoplasms; Carboplatin; Docetaxel; Fatigue; Female; Filgrastim; Granulocyte Colony-Stimulating Factor; Humans; Middle Aged; Neoadjuvant Therapy; Polyethylene Glycols; Preoperative Period; Recombinant Proteins; Taxoids; Thrombocytopenia; Treatment Outcome

2013
Effect of abiraterone acetate on fatigue in patients with metastatic castration-resistant prostate cancer after docetaxel chemotherapy.
    Annals of oncology : official journal of the European Society for Medical Oncology, 2013, Volume: 24, Issue:4

    Topics: Abiraterone Acetate; Androstadienes; Castration; Docetaxel; Fatigue; Humans; Male; Neoplasm Metastasis; Neoplasm Staging; Prednisone; Prostatic Neoplasms; Surveys and Questionnaires; Taxoids

2013
A randomized, active-control, pilot trial of front-loaded dosing regimens of darbepoetin-alfa for the treatment of patients with anemia during chemotherapy for malignant disease.
    Cancer, 2003, Mar-01, Volume: 97, Issue:5

    Topics: Aged; Anemia; Antineoplastic Combined Chemotherapy Protocols; Carboplatin; Darbepoetin alfa; Deoxycytidine; Docetaxel; Erythropoietin; Fatigue; Female; Gemcitabine; Humans; Injections, Subcutaneous; Male; Middle Aged; Neoplasms; Paclitaxel; Pilot Projects; Taxoids; Treatment Outcome

2003
Salvage treatment with docetaxel for recurrent epithelial ovarian cancer.
    International journal of clinical oncology, 2003, Volume: 8, Issue:6

    Topics: Adult; Aged; Antineoplastic Agents, Phytogenic; Asthenia; Docetaxel; Fatigue; Female; Humans; Infusions, Intravenous; Middle Aged; Neoplasm Recurrence, Local; Ovarian Neoplasms; Retrospective Studies; Salvage Therapy; Survival Analysis; Taxoids; Treatment Outcome

2003
Weekly docetaxel for patients with platinum/paclitaxel/irinotecan-resistant relapsed ovarian cancer: a phase I study.
    International journal of clinical oncology, 2003, Volume: 8, Issue:6

    Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Asthenia; Camptothecin; Cisplatin; Docetaxel; Drug Administration Schedule; Drug Resistance, Neoplasm; Fatigue; Female; Humans; Infusions, Intravenous; Irinotecan; Maximum Tolerated Dose; Middle Aged; Ovarian Neoplasms; Paclitaxel; Taxoids; Treatment Outcome

2003
Quality of life assessment of second-line docetaxel versus best supportive care in patients with non-small-cell lung cancer previously treated with platinum-based chemotherapy: results of a prospective, randomized phase III trial.
    Lung cancer (Amsterdam, Netherlands), 2004, Volume: 43, Issue:2

    Topics: Adult; Aged; Antineoplastic Agents, Phytogenic; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Non-Small-Cell Lung; Docetaxel; Fatigue; Female; Humans; Infusions, Intravenous; Lung Neoplasms; Male; Middle Aged; Pain; Quality of Life; Salvage Therapy; Survival Analysis; Taxoids

2004
[A randomized trial of docetaxol plus cisplatin versus gemzar plus cisplatin in treating advanced non-small cell lung cancer].
    Ai zheng = Aizheng = Chinese journal of cancer, 2005, Volume: 24, Issue:8

    Topics: Adolescent; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Non-Small-Cell Lung; Cisplatin; Deoxycytidine; Docetaxel; Fatigue; Female; Gemcitabine; Humans; Leukopenia; Lung Neoplasms; Male; Middle Aged; Neoplasm Staging; Remission Induction; Survival Rate; Taxoids; Thrombocytopenia

2005
Phase I trial of bortezomib in combination with docetaxel in patients with advanced solid tumors.
    Clinical cancer research : an official journal of the American Association for Cancer Research, 2006, Feb-15, Volume: 12, Issue:4

    Topics: Adult; Aged; Anemia; Antineoplastic Combined Chemotherapy Protocols; Area Under Curve; Boronic Acids; Bortezomib; Cytochrome P-450 CYP3A; Cytochrome P-450 Enzyme System; Docetaxel; Dose-Response Relationship, Drug; Fatigue; Female; Humans; Male; Metabolic Clearance Rate; Middle Aged; Neoplasms; Proteasome Endopeptidase Complex; Proteasome Inhibitors; Pyrazines; Taxoids; Treatment Outcome

2006
Assessment of tumor necrosis factor alpha blockade as an intervention to improve tolerability of dose-intensive chemotherapy in cancer patients.
    Journal of clinical oncology : official journal of the American Society of Clinical Oncology, 2006, Apr-20, Volume: 24, Issue:12

    Topics: Adult; Aged; Aged, 80 and over; Asthenia; Docetaxel; Dose-Response Relationship, Drug; Etanercept; Fatigue; Female; Humans; Immunoglobulin G; Immunologic Factors; Injections, Subcutaneous; Male; Middle Aged; Neoplasms; Receptors, Tumor Necrosis Factor; Taxoids; Treatment Outcome; Tumor Necrosis Factor-alpha

2006
Phase I safety, pharmacokinetic and pharmacodynamic studies of 2-methoxyestradiol alone or in combination with docetaxel in patients with locally recurrent or metastatic breast cancer.
    Investigational new drugs, 2007, Volume: 25, Issue:1

    Topics: 2-Methoxyestradiol; Administration, Oral; Adult; Aged; Antineoplastic Agents, Phytogenic; Antineoplastic Combined Chemotherapy Protocols; Area Under Curve; Breast Neoplasms; Docetaxel; Drug Administration Schedule; Estradiol; Fatigue; Female; Half-Life; Humans; Matrix Metalloproteinase 2; Matrix Metalloproteinase 9; Middle Aged; Neoplasm Metastasis; Neoplasm Recurrence, Local; Taxoids; Treatment Outcome; Tubulin Modulators; Urinalysis; Vascular Cell Adhesion Molecule-1; Vascular Endothelial Growth Factor A

2007
An open multicenter phase II trial of weekly docetaxel for advanced-stage non-small-cell lung cancer in elderly patients with significant comorbidity and/or poor performance status: The GFPC 02-02b study.
    Lung cancer (Amsterdam, Netherlands), 2007, Volume: 57, Issue:1

    Topics: Aged; Aged, 80 and over; Anemia; Antineoplastic Agents; Carcinoma, Non-Small-Cell Lung; Comorbidity; Diarrhea; Disease-Free Survival; Docetaxel; Drug Administration Schedule; Fatigue; Feasibility Studies; Female; Follow-Up Studies; Health Status; Humans; Lung Neoplasms; Male; Nausea; Neoplasm Staging; Quality of Life; Survival Analysis; Taxoids; Time Factors; Vomiting

2007
[Efficacy of docetaxel combined capecitabine on metastatic breast cancer].
    Ai zheng = Aizheng = Chinese journal of cancer, 2007, Volume: 26, Issue:4

    Topics: Administration, Oral; Adult; Antineoplastic Combined Chemotherapy Protocols; Bone Neoplasms; Breast Neoplasms; Capecitabine; Carcinoma, Ductal, Breast; Deoxycytidine; Disease-Free Survival; Docetaxel; Fatigue; Female; Fluorouracil; Follow-Up Studies; Humans; Infusions, Intravenous; Leukopenia; Liver Neoplasms; Lung Neoplasms; Lymphatic Metastasis; Middle Aged; Remission Induction; Taxoids

2007
Weekly docetaxel, zoledronic acid and estramustine in hormone-refractory prostate cancer (HRPC).
    Investigational new drugs, 2008, Volume: 26, Issue:1

    Topics: Administration, Oral; Aged; Aged, 80 and over; Alopecia; Anemia; Antineoplastic Combined Chemotherapy Protocols; Bone Neoplasms; Diphosphonates; Docetaxel; Drug Administration Schedule; Drug Resistance, Neoplasm; Estramustine; Fatigue; Humans; Hypocalcemia; Imidazoles; Infusions, Intravenous; Injections, Intravenous; Male; Middle Aged; Prostate-Specific Antigen; Prostatic Neoplasms; Taxoids; Thrombocytopenia; Time Factors; Treatment Outcome; Zoledronic Acid

2008
A phase I pharmacological and biological study of PI-88 and docetaxel in patients with advanced malignancies.
    Cancer chemotherapy and pharmacology, 2008, Volume: 63, Issue:1

    Topics: Adult; Aged; Angiogenesis Inhibitors; Antineoplastic Combined Chemotherapy Protocols; Combined Modality Therapy; Docetaxel; Drug Administration Schedule; Fatigue; Female; Fibroblast Growth Factor 2; Gastrointestinal Diseases; Glucuronidase; Heparin; Humans; Male; Maximum Allowable Concentration; Middle Aged; Neoplasm Proteins; Neoplasms; Oligosaccharides; Partial Thromboplastin Time; Platelet Factor 4; Taxoids; Vascular Endothelial Growth Factor A

2008
A phase I study of docetaxel and bexarotene.
    Chemotherapy, 2008, Volume: 54, Issue:2

    Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Bexarotene; Docetaxel; Drug Administration Schedule; Fatigue; Female; Humans; Male; Middle Aged; Nausea; Neoplasms; Taxoids; Tetrahydronaphthalenes

2008
Docetaxel plus prednisolone for the treatment of metastatic hormone-refractory prostate cancer: a multicenter Phase II trial in Japan.
    Japanese journal of clinical oncology, 2008, Volume: 38, Issue:5

    Topics: Aged; Alopecia; Anorexia; Antineoplastic Agents, Hormonal; Antineoplastic Combined Chemotherapy Protocols; Docetaxel; Drug Administration Schedule; Drug Resistance, Neoplasm; Fatigue; Feasibility Studies; Humans; Japan; Leukopenia; Male; Middle Aged; Neutropenia; Prednisolone; Prostate-Specific Antigen; Prostatic Neoplasms; Taxoids; Treatment Outcome

2008
Pharmacokinetics and metabolism of docetaxel administered as a 1-h intravenous infusion.
    Cancer chemotherapy and pharmacology, 2000, Volume: 45, Issue:3

    Topics: Adult; Aged; Alanine Transaminase; Alkaline Phosphatase; Alopecia; Antineoplastic Agents, Phytogenic; Area Under Curve; Aspartate Aminotransferases; Breast Neoplasms; Diarrhea; Docetaxel; Fatigue; Female; Humans; Infusions, Intravenous; Male; Metabolic Clearance Rate; Middle Aged; Mouth Mucosa; Neoplasms; Neutropenia; Paclitaxel; Stomatitis; Taxoids; Time Factors

2000
The orally administered P-glycoprotein inhibitor R101933 does not alter the plasma pharmacokinetics of docetaxel.
    Clinical cancer research : an official journal of the American Association for Cancer Research, 2000, Volume: 6, Issue:4

    Topics: Administration, Oral; Adult; Aged; Antineoplastic Agents, Phytogenic; Area Under Curve; ATP Binding Cassette Transporter, Subfamily B, Member 1; Benzazepines; Docetaxel; Dose-Response Relationship, Drug; Fatigue; Female; Humans; Male; Middle Aged; Mouth Mucosa; Neoplasms; Neutropenia; Paclitaxel; Quinolines; Stomatitis; Taxoids; Vomiting

2000
Docetaxel-carboplatin as first line chemotherapy for epithelial ovarian cancer.
    British journal of cancer, 2001, Volume: 84, Issue:2

    Topics: Adenocarcinoma; Adult; Aged; Aged, 80 and over; Antineoplastic Combined Chemotherapy Protocols; Carboplatin; Constipation; Diarrhea; Docetaxel; Dose-Response Relationship, Drug; Fatigue; Female; Hematologic Diseases; Humans; Middle Aged; Nausea; Neoplasm Staging; Ovarian Neoplasms; Paclitaxel; Prospective Studies; Survival Analysis; Taxoids; Treatment Outcome; Vomiting

2001
A phase II study of sequential chemotherapy with docetaxel after the weekly PELF regimen in advanced gastric cancer. A report from the Italian group for the study of digestive tract cancer.
    British journal of cancer, 2001, Volume: 84, Issue:4

    Topics: Adult; Aged; Antineoplastic Agents, Phytogenic; Antineoplastic Combined Chemotherapy Protocols; Cisplatin; Docetaxel; Drug Administration Schedule; Drug Therapy, Combination; Epirubicin; Fatigue; Female; Fluorouracil; Glutathione; Granulocyte Colony-Stimulating Factor; Humans; Infusions, Intravenous; Injections, Subcutaneous; Leucovorin; Male; Middle Aged; Neutropenia; Paclitaxel; Stomach Neoplasms; Taxoids; Thrombocytopenia; Treatment Outcome

2001
Treatment of advanced breast cancer with docetaxel and gemcitabine with and without human granulocyte colony-stimulating factor.
    Clinical cancer research : an official journal of the American Association for Cancer Research, 2002, Volume: 8, Issue:5

    Topics: Adult; Aged; Anemia; Antineoplastic Combined Chemotherapy Protocols; Breast Neoplasms; Deoxycytidine; Docetaxel; Fatigue; Female; Gemcitabine; Granulocyte Colony-Stimulating Factor; Humans; Leukopenia; Middle Aged; Nausea; Nervous System Diseases; Paclitaxel; Survival Analysis; Taxoids; Treatment Outcome

2002

Other Studies

8 other study(ies) available for docetaxel anhydrous and Lassitude

ArticleYear
A rare case of docetaxel-induced myositis in a patient with a lung adenocarcinoma.
    Thoracic cancer, 2022, Volume: 13, Issue:14

    Topics: Adenocarcinoma of Lung; Aged; Carcinoma, Non-Small-Cell Lung; Docetaxel; Fatigue; Humans; Lung Neoplasms; Male; Myositis; Pain

2022
The role of frailty in modifying physical function and quality of life over time in older men with metastatic castration-resistant prostate cancer.
    Journal of geriatric oncology, 2023, Volume: 14, Issue:2

    Topics: Activities of Daily Living; Aged; Docetaxel; Fatigue; Frailty; Humans; Male; Pain; Prospective Studies; Prostatic Neoplasms, Castration-Resistant; Quality of Life

2023
Toxicity profile of taxanes in Tunisian cancer patients: A retrospective study of 90 cases.
    Bulletin du cancer, 2021, Volume: 108, Issue:3

    Topics: Adult; Aged; Alopecia; Antineoplastic Agents; Breast Neoplasms; Cisplatin; Digestive System Diseases; Docetaxel; Fatigue; Female; Fluorouracil; Hematologic Diseases; Humans; Male; Middle Aged; Nail Diseases; Nervous System Diseases; Ovarian Neoplasms; Paclitaxel; Prostatic Neoplasms; Retrospective Studies; Stomach Neoplasms; Taxoids; Tunisia

2021
U.S. Food and Drug Administration Approval Summary: Atezolizumab for Metastatic Non-Small Cell Lung Cancer.
    Clinical cancer research : an official journal of the American Association for Cancer Research, 2017, Aug-15, Volume: 23, Issue:16

    Topics: Adult; Aged; Aged, 80 and over; Antibodies, Monoclonal; Antibodies, Monoclonal, Humanized; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Non-Small-Cell Lung; Docetaxel; Drug Approval; Dyspnea; Fatigue; Female; Humans; Kaplan-Meier Estimate; Lung Neoplasms; Male; Middle Aged; Randomized Controlled Trials as Topic; Taxoids; Treatment Outcome; United States; United States Food and Drug Administration

2017
Ecological momentary assessment of sleep, symptoms, and mood during chemotherapy for breast cancer.
    Psycho-oncology, 2014, Volume: 23, Issue:11

    Topics: Adult; Affect; Aged; Antineoplastic Agents; Antineoplastic Combined Chemotherapy Protocols; Anxiety; Breast Neoplasms; Cohort Studies; Computers, Handheld; Cyclophosphamide; Data Collection; Depression; Docetaxel; Doxorubicin; Fatigue; Female; Fluorouracil; Humans; Middle Aged; Paclitaxel; Sleep; Taxoids

2014
Docetaxel in castration-resistant prostate cancer: a single-centre experience.
    Cancer investigation, 2014, Volume: 32, Issue:9

    Topics: Administration, Intravenous; Aged; Aged, 80 and over; Anemia; Antineoplastic Agents; Docetaxel; Drug Administration Schedule; Fatigue; Humans; Kaplan-Meier Estimate; Leukopenia; Male; Middle Aged; Outcome Assessment, Health Care; Proportional Hazards Models; Prostatic Neoplasms, Castration-Resistant; Taxoids

2014
The longitudinal relationship between fatigue and sleep in breast cancer patients undergoing chemotherapy.
    Sleep, 2012, Feb-01, Volume: 35, Issue:2

    Topics: Actigraphy; Antineoplastic Combined Chemotherapy Protocols; Breast Neoplasms; Cross-Sectional Studies; Cyclophosphamide; Docetaxel; Doxorubicin; Fatigue; Female; Fluorouracil; Humans; Longitudinal Studies; Middle Aged; Paclitaxel; Prospective Studies; Sleep; Sleep Wake Disorders; Taxoids

2012
The preliminary results of docetaxel-prednisolone combination therapy for the Japanese patients with hormone-refractory prostate cancer.
    Hinyokika kiyo. Acta urologica Japonica, 2007, Volume: 53, Issue:2

    Topics: Administration, Oral; Aged; Ambulatory Care; Docetaxel; Drug Administration Schedule; Drug Therapy, Combination; Fatigue; Feasibility Studies; Granulocyte Colony-Stimulating Factor; Humans; Infusions, Intravenous; Liver Neoplasms; Lymphatic Metastasis; Male; Middle Aged; Nausea; Neoplasm Staging; Neutropenia; Prednisolone; Prostate-Specific Antigen; Prostatic Neoplasms; Taxoids

2007